TriangleFOR PATIENTS · SOURCE READING
Certain factors affect prognosis (chance of recovery) and treatment options.
Source: Myelodysplastic/ Myeloproliferative Neoplasms Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: March 6, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
The prognosis and treatment options for CMML depend on:
Source links and citations
the number of white blood cells or platelets in the blood or bone marrow
whether the patient is anemic
Source links and citations
the amount of blasts in the blood or bone marrow
the amount of hemoglobin in red blood cells
Source links and citations
whether there are certain changes in the chromosomes
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice